Adiponectin Testing Market Trends

Growth Drivers

• Growing Number of People Obesity Around the World - The increasing disposable income of people is estimated to show an increase in the consumption of more food. The growing preference of people towards processed, canned, fried, and baked foods are rising day by day leading to high-calorie intake. Lack of physical exercise and intake of extra calories leaves people in an obese state. The adoption of eating junk food, readymade food, and food from outside vendors where a lot of oil, spices, cheese, and other high-calorie ingredients are used. Adiponectin is at a low level in obese people. As of 2022, there are over 1 billion people around the world with obesity with over 600 adults, over 300 adolescents, and about 40 million children.

• Increasing Adoption of Adipose-Derived Products - The adipose-derived stem cells are estimated to reach a value of about 3 billion by the end of 2030 from over 1 billion in 2021 globally.

• Higher Prevalence of Cardio-Metabolic Diseases Across the Globe - According to the estimations, more than 30 million people in the U.S. suffer from metabolic syndromes such as diabetes and cardiovascular disease as the major cause of death.

• Increasing Healthcare Expenditure for Research and Development Across the World – The national healthcare spending of the U.S. in 2021 increased by 3% with over USD 4 trillion per person.

Challenges

• Less Availability of Adiponectin Testing Kits - The availability of adiponectin kits is very less in many countries with less economic development. These countries do not have such facilities to provide diagnostic testing. The market growth is also estimated to be hindered by the poor medical and healthcare services in these respective regions.
• Requirement for Higher Initial Investment
• Availability of Other Testing Markers in the Market